Respiratory causes of infant mortality: Progress and challenges

American Journal of Perinatology

Volumn 27, Issue 7, 2010, Pages 549-558

  Barber, Melissa ^a   Blaisdell, Carol J ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Bronchopulmonary dysplasia; meconium aspiration syndrome; pulmonary vascular disease

Indexed keywords

ARTICLE; CHILD DEATH; HEALTH DISPARITY; HUMAN; INFANT; INFANT MORTALITY; NEWBORN; PRIORITY JOURNAL; RACE DIFFERENCE; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY TRACT MALFORMATION; SEX DIFFERENCE; UNITED STATES; BRONCHOPULMONARY DYSPLASIA; MECONIUM ASPIRATION SYNDROME; MORTALITY; NEONATAL RESPIRATORY DISTRESS SYNDROME; RESPIRATORY SYSTEM ABNORMALITIES; RESPIRATORY TRACT DISEASE; TRENDS; VASCULAR DISEASES;

BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT; INFANT, NEWBORN; MECONIUM ASPIRATION SYNDROME; MORTALITY; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RESPIRATORY SYSTEM ABNORMALITIES; RESPIRATORY TRACT DISEASES; UNITED STATES; VASCULAR DISEASES;

EID: 77954878009     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0030-1248942     Document Type: Article

References (36)

1. Kung H C., Hoyert D L., Xu J, Murphy S L. Deaths: final data for 2005. Natl Vital Stat Rep 2008 56 1-120
2. Mathews T J., MacDorman M F. Infant mortality statistics from the 2005 period linked birth/infant death data set. Natl Vital Stat Rep 2008 57 1-32
3. Singh G K., Yu S M. Infant mortality in the United States: trends, differentials, and projections, 1950 through 2010. Am J Public Health 1995 85 957-964
4. Muhuri P K., MacDorman M F., Ezzati-Rice T M. Racial differences in leading causes of infant death in the United States. Paediatr Perinat Epidemiol 2004 18 51-60
5. Malloy M H., Hartford R B., Kleinman J C. Trends in mortality caused by respiratory distress syndrome in the United States, 1969-83. Am J Public Health 1987 77 1511-1514
6. Engle W A., American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008 121 419-432
7. Poulain F R., Clements J A. Pulmonary surfactant therapy. West J Med 1995 162 43-50
8. Clements J A., Avery M E. Lung surfactant and neonatal respiratory distress syndrome. Am J Respir Crit Care Med 1998 157 (4 Pt 2) S59-S66
9. Lee K, Khoshnood B, Wall S N., Chang Y, Hsieh H L., Singh J K. Trend in mortality from respiratory distress syndrome in the United States, 1970-1995. J Pediatr 1999 134 434-440
10. Schoendorf K C., Kiely J L. Birth weight and age-specific analysis of the 1990 US infant mortality drop. Was it surfactant? Arch Pediatr Adolesc Med 1997 151 129-134
11. Kinsella J P., Greenough A, Abman S H. Bronchopulmonary dysplasia. Lancet 2006 367 1421-1431
12. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995 273 413-418
13. Crowley P, Chalmers I, Keirse M J. The effects of corticosteroid administration before preterm delivery: An overview of the evidence from controlled trials. Br J Obstet Gynaecol 1990 97 11-25
14. Hallman M, Haataja R. Genetic basis of respiratory distress syndrome. Front Biosci 2007 12 2670-2682
15. Horbar J D. Antenatal corticosteroid treatment and neonatal outcomes for infants 501 to 1500 gm in the Vermont-Oxford Trials Network. Am J Obstet Gynecol 1995 173 275-281
16. Guinn D A., Atkinson M W., Sullivan L et al. Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: a randomized controlled trial. JAMA 2001 286 1581-1587
17. Hayes E J., Paul D A., Stahl G E. et al. Effect of antenatal corticosteroids on survival for neonates born at 23 weeks of gestation. Obstet Gynecol 2008 111 921-926
18. McEvoy C, Schilling D, Spitale P, Peters D, O'Malley J, Durand M. Decreased respiratory compliance in infants less than or equal to 32 weeks' gestation, delivered more than 7 days after antenatal steroid therapy. Pediatrics 2008 121 e1032-e1038
19. Ranganathan D, Wall S, Khoshnood B, Singh J K., Lee K S. Racial differences in respiratory-related neonatal mortality among very low birth weight infants. J Pediatr 2000 136 454-459
20. St John E B., Carlo W A. Respiratory distress syndrome in VLBW infants: changes in management and outcomes observed by the NICHD Neonatal Research Network. Semin Perinatol 2003 27 288-292
21. Perelman R H., Farrell P M. Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease. Pediatrics 1982 70 570-575
22. Alexander G R., Kogan M, Bader D, Carlo W, Allen M, Mor J. US birth weight/gestational age-specific neonatal mortality: 1995-1997 rates for whites, Hispanics, and blacks. Pediatrics 2003 111 e61-e66
23. Statistical abstract of the United States: 2001. Washington, DC U.S. Census Bureau 2001
24. Stevens T P., Harrington E W., Blennow M, Soll R F. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome Review. Cochrane Database Syst Rev 2007 4 CD003063
25. Malloy M H., Freeman D H. Respiratory distress syndrome mortality in the United States, 1987 to 1995. J Perinatol 2000 20 414-420
26. Frisbie W P., Song S E., Powers D A., Street J A. The increasing racial disparity in infant mortality: respiratory distress syndrome and other causes. Demography 2004 41 773-800
27. Hamvas A, Wise P H., Yang R K. et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. N Engl J Med 1996 334 1635-1640
28. Buehler J W., Strauss L T., Hogue C J., Smith J C. Birth weight-specific causes of infant mortality, United States, 1980. Public Health Rep 1987 102 162-171
29. Kobaly K, Schluchter M, Minich N et al. Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics 2008 121 73-81
30. Geary C, Caskey M, Fonseca R, Malloy M. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study. Pediatrics 2008 121 89-96
31. Wise P H. The future pediatrician: the challenge of chronic illness. J Pediatr 2007 151 (5 Suppl) S6-S10
32. Carmichael S L., Iyasu S, Hatfield-Timajchy K. Cause-specific trends in neonatal mortality among black and white infants, United States, 19801995. Matern Child Health J 1998 2 67-76
33. Yee W, Amin H, Wood S. Elective cesarean delivery, neonatal intensive care unit admission, and neonatal respiratory distress. Obstet Gynecol 2008 111 823-828
34. Soll R F. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000 (2) CD001079
35. Barton L, Hodgman J E., Pavlova Z. Causes of death in the extremely low birth weight infant. Pediatrics 1999 103 446-451
36. Cuevas K D., Silver D R., Brooten D, Youngblut J M., Bobo C M. The cost of prematurity: hospital charges at birth and frequency of rehospitalizations and acute care visits over the first year of life: a comparison by gestational age and birth weight. Am J Nurs 2005 105 56-64 quiz 65